This dual function can activate DNA replication origins while simultaneously leading to transcriptional repression, serving as a "molecular switch." Given these findings, CDC6 holds potential as a therapeutic target, particularly in the context of CRC and cancer therapy. Here, CDC6 is linked to colorectal carcinoma.